SI2366703T1 - Polimorfna oblika 2-amino (nitroaril) tiazolnega derivata - Google Patents

Polimorfna oblika 2-amino (nitroaril) tiazolnega derivata

Info

Publication number: SI2366703T1
Authority: SI; Slovenia
Prior art keywords: nitroaryl; amino; polymorph form; thiazole derivative; thiazole
Prior art date: 2007-02-13

Application number

SI200831294T

Other languages

English (en)

Inventor

Alain Moussy

Philippe Reginault

Francois Bellamy

Anne Lermet

Original Assignee

Ab Science

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-13

Filing date

2008-02-13

Publication date

2014-10-30

2008-02-13 Application filed by Ab Science filed Critical Ab Science

2014-10-30 Publication of SI2366703T1 publication Critical patent/SI2366703T1/sl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

SI200831294T 2007-02-13 2008-02-13 Polimorfna oblika 2-amino (nitroaril) tiazolnega derivata SI2366703T1 (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US88958707P	2007-02-13	2007-02-13
EP11170200.7A EP2366703B1 (en)	2007-02-13	2008-02-13	Polymorph form of 2-amino (nitroaryl) thiazole derivative

Publications (1)

Publication Number	Publication Date
SI2366703T1 true SI2366703T1 (sl)	2014-10-30

Family

ID=39332208

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI200830399T SI2118099T1 (sl)	2007-02-13	2008-02-13	Postopek za sintezo 2-aminotiazolnih spojin kot kinaznih inhibitorjev
SI200831294T SI2366703T1 (sl)	2007-02-13	2008-02-13	Polimorfna oblika 2-amino (nitroaril) tiazolnega derivata

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SI200830399T SI2118099T1 (sl)	2007-02-13	2008-02-13	Postopek za sintezo 2-aminotiazolnih spojin kot kinaznih inhibitorjev

Country Status (23)

Country	Link
US (3)	US8153792B2 (sl)
EP (2)	EP2366703B1 (sl)
JP (2)	JP5568312B2 (sl)
KR (1)	KR20090110851A (sl)
CN (2)	CN101657446B (sl)
AR (1)	AR065337A1 (sl)
AT (1)	ATE515506T1 (sl)
AU (1)	AU2008214679A1 (sl)
BR (1)	BRPI0807626B1 (sl)
CA (2)	CA2677586C (sl)
ES (2)	ES2522169T3 (sl)
HR (2)	HRP20110709T1 (sl)
IL (1)	IL200320A0 (sl)
MA (1)	MA31180B1 (sl)
MX (1)	MX2009008665A (sl)
NZ (1)	NZ578944A (sl)
PL (2)	PL2118099T3 (sl)
RU (2)	RU2456285C2 (sl)
SI (2)	SI2118099T1 (sl)
TN (1)	TN2009000342A1 (sl)
TW (1)	TWI406862B (sl)
WO (1)	WO2008098949A2 (sl)
ZA (1)	ZA200905981B (sl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2294344T3 (es)	2002-08-02	2008-04-01	Ab Science	2-(3-aminoaril)amino-4-aril-tiazoles y su utilizacion como inhibidores de c-kit.
US8450302B2 (en)	2002-08-02	2013-05-28	Ab Science	2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US20120302577A1 (en)	2010-01-28	2012-11-29	Ab Science	Treatment of gist with masitinib
AR080096A1 (es)	2010-02-01	2012-03-14	Ab Science	Tratamiento combinado de cancer de pancreas con gemcitabina y masitinib
AR080380A1 (es)	2010-03-09	2012-04-04	Ab Science	Tratamiento de la demencia tipo alzheimer con masitinib
AR080933A1 (es)	2010-04-20	2012-05-16	Ab Science	Tratamiento de esclerosis multiple con masitinib
TW201204719A (en)	2010-06-02	2012-02-01	Ab Science	Treatment of rheumatoid arthritis with masitinib
WO2012059526A1 (en)	2010-11-05	2012-05-10	Ab Science	Treatment of mastocytosis with masitinib
US10045978B2 (en)	2010-11-05	2018-08-14	Ab Science	Treatment of mastocytosis with masitinib
WO2012104402A1 (en) *	2011-02-04	2012-08-09	Ab Science	Treatment of severe persitent asthma with masitinib
WO2012136732A1 (en)	2011-04-08	2012-10-11	Ab Science	Treatment of multiple myeloma with masitinib
SI2903616T1 (sl)	2012-10-04	2018-02-28	Ab Science	Uporaba masitiniba v kombinaciji z gemcitabinom za zdravljenje podskupine pacientov, ki trpijo za rakom slinavke
WO2015082496A1 (en)	2013-12-02	2015-06-11	Ab Science	Use of masitinib for treatment of colorectal cancer
EP2886543A1 (en)	2013-12-18	2015-06-24	Sandoz Ag	Crystalline form of mastinib mesylate
WO2015185958A1 (en)	2014-06-02	2015-12-10	Ab Science	Use of an inhibitor of kinase activity, particularly masitinib, for treatment of prostate cancer
CN105585556A (zh) *	2014-11-13	2016-05-18	连云港杰瑞药业有限公司	一种伊马替尼的合成方法
CN106794179A (zh) *	2015-07-29	2017-05-31	苏州晶云药物科技有限公司	马赛替尼甲磺酸盐的新晶型及其制备方法
CA3000894A1 (en)	2015-10-05	2017-04-13	Ab Science	Treatment of severe systemic mastocytosis with masitinib
EP3240538B1 (en)	2016-03-25	2021-09-29	AB Science	Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
US10961235B2 (en)	2017-03-31	2021-03-30	Sandoz Ag	Crystalline form of masitinib
US10696638B2 (en)	2017-12-26	2020-06-30	Industrial Technology Research Institute	Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising the same
EP4061371A1 (en)	2019-11-22	2022-09-28	AB Science	Masitinib for the treatment of sickle cell disease
EP3831384A1 (en)	2019-12-02	2021-06-09	AB Science	Use of masitinib for the treatment of eosinophilic asthma
CN115515590A (zh)	2020-02-20	2022-12-23	Ab科学有限公司	马赛替尼用于治疗多发性硬化患者亚群
CN115867278A (zh)	2020-04-10	2023-03-28	Ab科学有限公司	马赛替尼用于治疗2019冠状病毒病(covid-19)的用途
WO2022129410A1 (en)	2020-12-16	2022-06-23	Ab Science	Masitinib for the treatment of alzheimer's disease
IL308088A (en)	2021-05-17	2023-12-01	Ab Science	Mestitinib for the treatment of castrate-resistant prostate cancer
CN115850258A (zh) *	2022-12-27	2023-03-28	东北林业大学	一种马赛替尼的合成方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3299087A (en) *	1961-04-24	1967-01-17	Geigy Chem Corp	Nu, nu'-bis-(thiazolyl)-phenylenediamines
WO1998052937A2 (en) *	1997-05-22	1998-11-26	G.D. Searle And Co.	4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
CO4940418A1 (es) *	1997-07-18	2000-07-24	Novartis Ag	Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
GB9718913D0 (en) *	1997-09-05	1997-11-12	Glaxo Group Ltd	Substituted oxindole derivatives
YU22400A (sh) *	1997-10-27	2003-08-29	Agouron Pharmaceuticals Inc.	Supstituisana 4-amino-tiazol-2-i jedinjenja kao cdks inhibitori
US6114365A (en) *	1999-08-12	2000-09-05	Pharmacia & Upjohn S.P.A.	Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
ATE309241T1 (de) *	1999-09-10	2005-11-15	Merck & Co Inc	Tyrosin kinase inhibitoren
ATE376182T1 (de)	2001-06-29	2007-11-15	Ab Science	C-kit inhibitoren
EP1401429A2 (en)	2001-06-29	2004-03-31	AB Science	Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
JP2004530730A (ja)	2001-06-29	2004-10-07	アブサイエンス	腫瘍の血管新生を治療するための強力で選択的かつ非毒性のｃ−ｋｉｔ阻害剤の使用法
JP2005502614A (ja)	2001-06-29	2005-01-27	アブサイエンス	多発性硬化症（ｍｓ）を治療するためのチロシンキナーゼ阻害剤の使用方法
JP2004536097A (ja)	2001-06-29	2004-12-02	アブサイエンス	自己免疫疾患を治療するためのチロシンキナーゼ阻害剤の使用法
US7700610B2 (en)	2001-06-29	2010-04-20	Ab Science	Use of tyrosine kinase inhibitors for treating allergic diseases
US7678805B2 (en)	2001-06-29	2010-03-16	Ab Science	Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)
EP1401411A2 (en)	2001-06-29	2004-03-31	AB Science	Use of tyrosine kinase inhibitors for treating bone loss
JP2004537537A (ja)	2001-06-29	2004-12-16	アブサイエンス	炎症性疾患を治療するためのチロシンキナーゼ阻害剤の使用法
US20030091974A1 (en)	2001-06-29	2003-05-15	Alain Moussy	Method for screening compounds capable of depleting mast cells
US20040242612A1 (en)	2001-09-20	2004-12-02	Alain Moussy	Use of tyrosine kinase inhibitors for promoting hair growth
DE60225590T2 (de)	2001-09-20	2008-09-25	Ab Science	C-kithemmer zur behandlung von bakteriellen infektionen
JP2005511596A (ja)	2001-09-20	2005-04-28	アブサイエンス	ヒトの皮膚を白くし、且つメラノサイト機能不全関連疾病を治療するためのチロシンキナーゼ阻害剤の使用方法
WO2003072106A2 (en)	2002-02-27	2003-09-04	Ab Science	Use of tyrosine kinase inhibitors for treating substance use disorders
WO2003072090A2 (en)	2002-02-27	2003-09-04	Ab Science	Use of tyrosine kinase inhibitors for treating cns disorders
EP1507776B1 (en) *	2002-05-29	2007-02-28	Amgen Inc.	2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
ES2294344T3 (es) *	2002-08-02	2008-04-01	Ab Science	2-(3-aminoaril)amino-4-aril-tiazoles y su utilizacion como inhibidores de c-kit.
SE0202462D0 (sv) *	2002-08-14	2002-08-14	Astrazeneca Ab	Novel use
WO2004072068A1 (en) *	2003-02-10	2004-08-26	Amgen Inc.	Vanilloid receptor ligands and their use in treatments
JP2006519220A (ja)	2003-02-27	2006-08-24	アブサイエンス	異なる型の肥満細胞症に適合可能なテイラーメイド治療方法
FR2854158B1 (fr) *	2003-04-25	2006-11-17	Sanofi Synthelabo	Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
MXPA06001098A (es) *	2003-07-29	2006-04-24	Irm Llc	Compuestos y composiciones utiles como inhibidores de proteina cinasa.
EP1653934B1 (en)	2003-08-15	2008-05-14	AB Science	Use of c-kit inhibitors for treating type ii diabetes
US7363881B2 (en)	2003-11-06	2008-04-29	Nova-Tech Engineering, Inc.	Beak treatment with tongue protection
CN101456841B (zh)	2003-12-25	2012-01-25	日本新药株式会社	酰胺衍生物及医药品
US7650848B2 (en) *	2004-02-17	2010-01-26	University Of Florida Research Foundation, Inc.	Surface topographies for non-toxic bioadhesion control
WO2005115385A1 (en) *	2004-05-24	2005-12-08	Ab Science	Use of c-kit inhibitors for treating acne
TW200702876A (en) *	2005-07-04	2007-01-16	Avermedia Tech Inc	Projector device capable of sychronously encoding audio and video to become AV sychronous paly file

2008
- 2008-02-13 WO PCT/EP2008/051704 patent/WO2008098949A2/en active Application Filing
- 2008-02-13 PL PL08708929T patent/PL2118099T3/pl unknown
- 2008-02-13 SI SI200830399T patent/SI2118099T1/sl unknown
- 2008-02-13 TW TW097105021A patent/TWI406862B/zh active
- 2008-02-13 EP EP11170200.7A patent/EP2366703B1/en active Active
- 2008-02-13 CA CA2677586A patent/CA2677586C/en active Active
- 2008-02-13 CA CA2970628A patent/CA2970628C/en active Active
- 2008-02-13 EP EP08708929A patent/EP2118099B1/en active Active
- 2008-02-13 ES ES11170200.7T patent/ES2522169T3/es active Active
- 2008-02-13 CN CN2008800049044A patent/CN101657446B/zh active Active
- 2008-02-13 PL PL11170200T patent/PL2366703T3/pl unknown
- 2008-02-13 KR KR1020097016822A patent/KR20090110851A/ko not_active Application Discontinuation
- 2008-02-13 AU AU2008214679A patent/AU2008214679A1/en not_active Abandoned
- 2008-02-13 AT AT08708929T patent/ATE515506T1/de not_active IP Right Cessation
- 2008-02-13 JP JP2009549405A patent/JP5568312B2/ja active Active
- 2008-02-13 ES ES08708929T patent/ES2369617T3/es active Active
- 2008-02-13 AR ARP080100620A patent/AR065337A1/es active IP Right Grant
- 2008-02-13 US US12/526,827 patent/US8153792B2/en active Active
- 2008-02-13 NZ NZ578944A patent/NZ578944A/en unknown
- 2008-02-13 SI SI200831294T patent/SI2366703T1/sl unknown
- 2008-02-13 MX MX2009008665A patent/MX2009008665A/es active IP Right Grant
- 2008-02-13 RU RU2009132186/04A patent/RU2456285C2/ru active
- 2008-02-13 CN CN201310141370.2A patent/CN103342701B/zh active Active
- 2008-02-13 BR BRPI0807626-0A patent/BRPI0807626B1/pt active IP Right Grant
2009
- 2009-08-10 IL IL200320A patent/IL200320A0/en unknown
- 2009-08-11 MA MA32161A patent/MA31180B1/fr unknown
- 2009-08-11 TN TNP2009000342A patent/TN2009000342A1/fr unknown
- 2009-08-28 ZA ZA2009/05981A patent/ZA200905981B/en unknown
2011
- 2011-10-05 HR HR20110709T patent/HRP20110709T1/hr unknown
2012
- 2012-03-08 US US13/415,249 patent/US8492545B2/en active Active
- 2012-04-12 RU RU2012114234/04A patent/RU2491286C1/ru active
2013
- 2013-05-10 US US13/891,639 patent/US8940894B2/en active Active
- 2013-05-30 JP JP2013113789A patent/JP5784073B2/ja active Active
2014
- 2014-10-15 HR HRP20140986AT patent/HRP20140986T1/hr unknown

Also Published As

Publication number	Publication date
CN103342701B (zh)	2016-09-21
US8492545B2 (en)	2013-07-23
ZA200905981B (en)	2010-11-24
CN103342701A (zh)	2013-10-09
HRP20140986T1 (hr)	2014-11-21
JP2010518141A (ja)	2010-05-27
KR20090110851A (ko)	2009-10-22
EP2366703A1 (en)	2011-09-21
RU2456285C2 (ru)	2012-07-20
WO2008098949A2 (en)	2008-08-21
BRPI0807626A2 (pt)	2014-11-25
JP2013177437A (ja)	2013-09-09
NZ578944A (en)	2011-03-31
EP2118099A2 (en)	2009-11-18
US8153792B2 (en)	2012-04-10
AU2008214679A1 (en)	2008-08-21
ATE515506T1 (de)	2011-07-15
JP5568312B2 (ja)	2014-08-06
CA2970628C (en)	2019-08-27
SI2118099T1 (sl)	2011-11-30
PL2366703T3 (pl)	2015-02-27
CN101657446B (zh)	2013-05-15
CN101657446A (zh)	2010-02-24
BRPI0807626B1 (pt)	2022-03-03
WO2008098949A3 (en)	2008-10-02
TWI406862B (zh)	2013-09-01
TN2009000342A1 (en)	2010-12-31
ES2369617T3 (es)	2011-12-02
CA2970628A1 (en)	2008-08-21
RU2009132186A (ru)	2011-03-20
MX2009008665A (es)	2009-08-21
HRP20110709T1 (hr)	2011-11-30
AR065337A1 (es)	2009-06-03
CA2677586C (en)	2017-07-25
ES2522169T3 (es)	2014-11-13
PL2118099T3 (pl)	2011-12-30
EP2366703B1 (en)	2014-07-30
CA2677586A1 (en)	2008-08-21
TW200848419A (en)	2008-12-16
US20120196871A1 (en)	2012-08-02
RU2491286C1 (ru)	2013-08-27
JP5784073B2 (ja)	2015-09-24
IL200320A0 (en)	2010-04-29
US20130289045A1 (en)	2013-10-31
US8940894B2 (en)	2015-01-27
EP2118099B1 (en)	2011-07-06
MA31180B1 (fr)	2010-02-01
US20100121063A1 (en)	2010-05-13

Publication	Publication Date	Title
PL2366703T3 (pl)	2015-02-27	Postać polimorficzna pochodnej 2-amino-(nitroarylo)-tiazolu
PL2614825T3 (pl)	2017-08-31	Sposób wytwarzania pochodnych tiazolu
EP2193127A4 (en)	2011-09-14	BENZOTHIAZOLE COMPOUNDS
IL206286A0 (en)	2010-12-30	Thiazole derivatives used as pi 3 kinase inhibitors
GB0812031D0 (en)	2008-08-06	Thiazole derivatives
GB0722216D0 (en)	2007-12-27	Use of crth2 antagonist compounds
GB0722203D0 (en)	2007-12-19	Use of CRTH2 antagonist compounds
HK1136559A1 (en)	2010-07-02	Process for the preparation of a benzimidazole derivative
IL205751A0 (en)	2010-11-30	Aminothiazole derivatives
IL204563A0 (en)	2010-11-30	Thiazole derivatives
EP2192838A4 (en)	2011-07-27	HETEROCYCLIC NEKROPTOSIS HEMMER
IL198847A0 (en)	2010-02-17	New process for the preparation of 2-imino-thiazolidin-4-one derivatives
IL195007A0 (en)	2009-08-03	Thiazole derivatives
IL199840A0 (en)	2010-04-15	Combinations of beta- 2 -adrenoceptor agonistic benzothiazolone
HK1206003A1 (zh)	2015-12-31	有治療價值的三苯基丁烯衍生物的製備方法
IL201189A0 (en)	2010-05-17	Fluorinated derivatives of deferiprone
EP2242493A4 (en)	2011-09-07	Gefitinib DERIVATIVES
GB0604899D0 (en)	2006-04-19	Derivatives of 18-glycyrrhetinic acid
SI2220152T1 (sl)	2013-02-28	Postopek za pripravo sestavka premreĹľevalnega sredstva
EP2195309A4 (en)	2013-04-24	SALT POLYMORPHS OF THE ESOMEPRAZOLE
PT2220060T (pt)	2016-11-25	Derivados de tetrahidrobenzotiazol
IL237789A0 (en)	2015-05-31	Methods for using thiazole history
IL205082A0 (en)	2010-11-30	Process for the preparation of tetranorlabdane derivatives
FI20070134A0 (fi)	2007-02-15	Menetelmä pelkistysainekoostumuksen valmistamiseksi
GB0618649D0 (en)	2006-11-01	Production of amines